Figure 3.
Use of optimal medical therapy (OMT) (aspirin or thienopyridine, β-blockers and statins) in the overall population and in the two groups of patients and OMT (aspirin or thienopyridine, β-blockers, statins and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) among eligible patients.

Use of optimal medical therapy (OMT) (aspirin or thienopyridine, β-blockers and statins) in the overall population and in the two groups of patients and OMT (aspirin or thienopyridine, β-blockers, statins and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) among eligible patients.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close